A common criticism of the medical marijuana industry is that a majority of patients are just feigning illnesses so they can get high legally. Potbotics co-founder David Goldstein do not deny that this is valid for marijuana users, yet sees much bigger issues that play within the industry.
“Right now doctors give a general cannabis recommendation. It’s just a card that says, ‘Cannabis may be beneficial to you.’ There is no followup, no background check into your medical history, there is no real education process. It leads to people abusing the system,” he says.
Discovered back in 2013, the biotech company looks to be of some help towards the change of how medical marijuana patients throughout the country which are being treated using three new revolutionary products.The first is called Brainbot, which allows physicians to use EEG (electroencephalography) helmets to gauge patients neurological reactions to various kinds of marijuana as a way to efficiently prescribe a particular strain.
Next is the Potbot app, which is a virtual budtender pretty much a cannabis bartender that is displayed in an app and in-store kiosk forms, and recommends strains and strengths based on a person’s illness and previous marijuana use.
Now, Nanpot scans the DNA of cannabis seeds to help marijuana cultivators streamline the growth of their plants for desired levels of THC and other active compounds.
Goldstein created the idea for cannabis products after watching an elderly family member suffer from pain and inflammation after an operation. “She had a very low quality of life with an opiate-based medication for pain relief. I started reading about cannabinol, about CBD [an ingredient in marijuana that relieves pain without any psychoactive effects],” he says. “I was able to get her a cannabis medical card and we were able to look at THC and CBD-infused topical creams, so she was never smoking it, but got a lot of relief from it. I was really galvanized by the fact that this is something other patients should have access to.”
Goldstein, who previously co-founded the marketing company Crowdpunch, thoroughly analyzed data from many investigative studies, particularly from ones in Israel, that are thought to be the world leader in medical marijuana, to develop the one of a kind Brainbot software. He then partnered up with his father, Dr. Baruch Goldstein, who uses EEG testing on people with pre- Alzheimer’s issues to evaluate the effectiveness of different drugs on various patients “I started really wondering why wasn’t this type of procedure in place for the cannabis industry,” he says.
A common criticism of the medical marijuana industry is that a majority of patients are just feigning illnesses so they can get high legally. Potbotics co-founder David Goldstein do not deny that this is valid for marijuana users, yet sees much bigger issues that play within the industry.
“Right now doctors give a general cannabis recommendation. It’s just a card that says, ‘Cannabis may be beneficial to you.’ There is no follow-up, no background check into your medical history, there is no real education process. It leads to people abusing the system,” he says.
Discovered back in 2013, the biotech company looks to be of some help towards the change of how medical marijuana patients throughout the country which are being treated using three new revolutionary products.The first is called Brainbot, which allows physicians to use EEG (electroencephalography) helmets to gauge patients neurological reactions to various kinds of marijuana as a way to efficiently prescribe a particular strain.
Next is the Potbot app, which is a virtual budtender pretty much a cannabis bartender that is displayed in an app and in-store kiosk forms, and recommends strains and strengths based on a person’s illness and previous marijuana use.
Now, Nanpot scans the DNA of cannabis seeds to help marijuana cultivators streamline the growth of their plants for desired levels of THC and other active compounds.
Goldstein created the idea for cannabis products after watching an elderly family member suffer from pain and inflammation after an operation. “She had a very low quality of life with an opiate-based medication for pain relief. I started reading about cannabinol, about CBD [an ingredient in marijuana that relieves pain without any psychoactive effects],” he says. “I was able to get her a cannabis medical card and we were able to look at THC and CBD-infused topical creams, so she was never smoking it, but got a lot of relief from it. I was really galvanized by the fact that this is something other patients should have access to.”
Goldstein, who previously co-founded the marketing company Crowdpunch, thoroughly analyzed data from many investigative studies, particularly from ones in Israel, that are thought to be the world leader in medical marijuana, to develop the one of a kind Brainbot software. He then partnered up with his father, Dr. Baruch Goldstein, who uses EEG testing on people with pre- Alzheimer’s issues to evaluate the effectiveness of different drugs on various patients “I started really wondering why wasn’t this type of procedure in place for the cannabis industry,” he says.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
